Table 1.
Characteristic data and analysis for patients with undetected early Charcot neuroarthropathy
| Group I | Group II | Mann–Whitney U test | P-value | |
|---|---|---|---|---|
| n | 7 | 15 | ||
| Age | 62.3 | 53.5 | ||
| Follow up (Weeks) | 49.9 +/− 21.7 | 114.4 +/− 58.8 | ||
| Time to correct diagnosis (weeks) | 4.1 +/− 0.7 | 8.7 +/− 6.8 | 24.5 | 0.0262 |
| Time from stage 0 to active Charcot (weeks) | 10.9 +/− 7.5 | |||
| Complications: | 14.30 % | 66.70 % | 25 | 0.0287 |
| Ulceration | 1 | 6 | ||
| Cellulitis | 3 | |||
| Wound Dehiscence | 2 | |||
| Septic Non-Union/Osteomyelitis | 1 | |||
| Hardware Complication | 1 | |||
| Tibial Fracture | 1 | |||
| Solid Organ Transplantation | 4 | |||
| Joint Location Involvement: | - | - | - | - |
| Forefoot | 0 | |||
| Midfoot | 12 | |||
| Hindfoot | 5 | |||
| Ankle | 5 | |||
| Multiple | 5 |
*Group I includes patients who did not progress to active Charcot foot
*Group II includes patients who did progress to active Charcot foot
Adapted from Wukich et al [4]. Characteristics from a population of people with early Charcot foot that either progressed to active CN or did not. The Group (Group II) who progressed to active CN endured a significant difference in overall complications and were diagnosed with CN much later than the group who did not progress to active Charcot foot (Group I)